PIK3CA and invasive breast carcinoma: In metastatic BrCa, PIK3CA hotspot mutations were detected in 23/27(85.2%) DNA samples isolated from CellSearch® cartridges and in 18/27(66.7%) paired plasma‐ctDNA samples.